ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer

Wang, Yuliang; Fan, Jiaqi; Chen, Tao; Xu, Lele; Liu, Pengyu; Xiao, Lijia; Wu, Tao; Zhou, Qingchun; Zheng, Qingyou; Liu, Chunxiao*; Chan, Franky Leung*; Wu, Dinglan*南方医科大学
Frontiers in Endocrinology2022-8-10DOI: 10.3389/fendo.2022.975623
7被引10阅读
引用收藏
分享

摘要

Background: Prostate cancer (PCa) is among the leading causes of cancer death worldwide. Ferroptosis refers to an iron-dependent form of regulated cell death and is involved in prostate tumorigenesis. A few ferroptosis-related gene signatures have been developed to predict the prognosis for PCa patients. However, previous signatures were typically established based on biochemical recurrence-free survival, which has proven not to be a good surrogate for overall survival (OS). This study aimed to construct a novel ferroptosis-related gene prognostic index ( FRGPI) to predict disease-free survival (DFS) and response to immunotherapy for PCa patients after radical prostatectomy. @@@ Methods: Gene expression and clinicopathological data on PCa patients were obtained from the TCGA database. Ferroptosis-related hub genes associated with DFS of PCa patients were identified by an in-depth bioinformatics analysis using a novel and comprehensive algorithm based on functional enrichment, consensus clustering, weighted gene co-expression network analysis (WGCNA), and protein-protein interaction (PPI) network construction. The FRGPI was established on the basis of the genes selected using multivariate cox regression analysis and further validated in two additional PCa cohorts. Next, the clinicopathological, molecular, and immune profiles were characterized and compared between FRGPI-high and FRGPI- low subgroups. Finally, the predictive role of the FRGPI in response to immunotherapy was estimated using a metastatic urothelial cancer cohort treated with an anti-PD-L1 agent. @@@ Results: The FRGPI was constructed based on four genes (E2F1, CDC20, TYMS, and NUP85), and FRGPI-high patients had worse DFS than FRGPI-low patients. Multivariate cox regression analysis revealed that FRGPI could act as an independent prognostic factor for PCa patients after radical prostatectomy. A prognostic nomogram comprising the FRGPI and other clinicopathological parameters was established to predict the DFS for PCa patients quantitatively. In addition, comprehensive results demonstrated that high FRGPI scores showed a significantly positive correlation with worse clinicopathological features, higher mutation counts, increased frequency of copy number variations (CNVs), higher homologous recombination deficiency (HRD) and immune scores, higher mRNAsi, and more importantly, enhanced sensitivity to immunotherapy. @@@ Conclusions: FRGPI is not only a promising and robust prognostic biomarker, but also a potential indicator of immunotherapeutic outcomes for PCa patients after radical prostatectomy.

学科与关键词

关键词
ferroptosisgene indexprognosisprostate cancerimmunotherapy
相关
加载中…
  • Establishment of novel ferroptosis-related prognostic subtypes correlating with immune dysfunction in prostate cancer patients
    Feng, Dechao*; Tuo, Zhouting; Wang, Jie; Ye, Luxia; Li, Dengxiong; Wu, Ruicheng; Wei, Wuran; Yang, Yubo*; Zhang, Chi*Heliyon, 2024, 10(1): e23495.
  • A Ferroptosis-Related Gene Prognostic Index to Predict Temozolomide Sensitivity and Immune Checkpoint Inhibitor Response for Glioma
    Cai, Yonghua; Liang, Xianqiu; Zhan, Zhengming; Zeng, Yu; Lin, Jie; Xu, Anqi; Xue, Shuaishuai; Xu, Wei; Chai, Peng; Mao, Yangqi; Song, Zibin; Han, Lei; Xiao, Jianqi*; Song, Ye*; Zhang, Xian*Frontiers in Cell and Developmental Biology, 2022, 9: 812422.被引 6
  • Characterization of a Pyroptosis-Related Signature for Prognosis Prediction and Immune Microenvironment Infiltration in Prostate Cancer
    Zhang, Guian; Luo, Yong; Dong, Weimin; Zhong, Weide*Computational and Mathematical Methods in Medicine, 2022, 2022: 8233840.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Endocrinology
发表日期
2022-08-10
卷期
第 13 卷
页码
975623
DOI
10.3389/fendo.2022.975623
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81802575, 82072830, 81974457, 81872283]; Science and Technology Project of Shenzhen [JCYJ20210324130607021]; Postdoctoral Research Foundation of China [2021M690072]; Natural Science Foundation of Guangdong Province, China [2019A1515012079]

作者

  • W

    Wang, Yuliang (第一作者)

    chinese univ hong kong · southern med univ

  • F

    Fan, Jiaqi

    southern med univ

查看全部 12 位作者收起作者
  • C

    Chen, Tao

    southern med univ

  • X

    Xu, Lele

    southern med univ

  • L

    Liu, Pengyu

    southern med univ

  • X

    Xiao, Lijia

    southern med univ

  • W

    Wu, Tao

    southern med univ

  • Z

    Zhou, Qingchun

    southern med univ

  • Z

    Zheng, Qingyou

    southern med univ

  • L

    Liu, Chunxiao (通讯)

    southern med univ

  • C

    Chan, Franky Leung (通讯)

    chinese univ hong kong

  • W

    Wu, Dinglan (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417